RYM — RYTHM, Inc.

Agrify Q3 2022 Earnings Call Summary

1. Key Financial Results and Metrics:

• Revenue: $7 million for Q3 2022, down 55.4% from $15.8 million in Q3 2021.
• Design and Build Revenue: Declined to $1.3 million from $13 million year-over-year, primarily due to a $5.3 million revenue deferral related to a lawsuit with Bud & Mary's.
• Extraction Revenue: $5.7 million recognized in Q3 2022, a new revenue stream for the company.
• Bookings: Approximately $11.2 million in Q3, with $5.6 million from extraction products.
• Net Loss: $46.3 million, or $17.33 per diluted share, compared to a loss of $9.8 million, or $4.68 per diluted share, in the prior year.
• Adjusted EBITDA: Loss of $28.8 million, worsening from a loss of $5.6 million year-over-year.
• Cash Position: $12.5 million at the end of Q3, down from $56.6 million at the end of 2021.

2. Strategic Updates and Business Highlights:

• Agrify is focusing on a Rapid Deployment Program (RDP), which has gained traction with three new customers in Illinois, Massachusetts, and South Africa, expected to generate $7.5 million in hardware sales.
• The PX10 Hydrocarbon extractor has been successfully commercialized, with installations planned at three customer facilities.
• The company is committed to cost-saving initiatives and operational efficiency to navigate industry downturns.
• Agrify received recognition for best cultivation technology at the Green Market Report's Tech Summit.

3. Forward Guidance and Outlook:

• Revenue guidance for the remainder of 2022 has been lowered to $65 million to $70 million, down from the previous range of $70 million to $75 million, primarily due to the deferred revenue from Bud & Mary's.
• The company anticipates strong performance in Q4, particularly in the extraction division, with approximately $3 million of business pushed from Q3.

4. Bad News, Challenges, or Points of Concern:

• The lawsuit with Bud & Mary's has created significant uncertainty, leading to deferred revenue recognition and a substantial impact on financial results.
• Operating expenses surged to $24.1 million, largely due to a $15 million increase in bad debt reserves related to Bud & Mary's.
• The company is under a cash spending limit imposed by its institutional lender, which constrained its ability to fulfill orders and impacted revenue realization.
• The backlog has materially decreased, primarily due to the removal of forward-looking recurring revenue amounts associated with the Bud & Mary's project.

5. Notable Q&A Insights:

• Management expressed confidence in recovering the deferred revenue from Bud & Mary's, citing both corporate and personal guarantees from its CEO.
• The extraction business is showing signs of recovery, with a strong pipeline and increased interest in new technologies.
• The RDP program is seen as a pivot in Agrify's business model, allowing customers to start with lower capital investments compared to the traditional TTK model.
• Supply chain issues are reportedly easing, although some construction delays persist.

Overall, while Agrify faces significant challenges due to the Bud & Mary's lawsuit and operational constraints, it is actively pursuing new opportunities and adapting its business model to navigate the current market environment.